Partial Nephrectomy Allowed By Anti CD₂₀ Antibody Treatment for Renal Cancer Associated with Acquired Haemophilia A

Tamas Kullmann, Annick Ankri, Marc-Olivier Bitker, Serge Herson, Olivier Benveniste

.
Department of Internal Medicine, Pitié-Salpêtrière Hospital, Assistance Publique – H?pitaux de Paris, Pierre et Marie Curie University, Paris, France.

DOI: 10.4236/jct.2011.23041                

Abstract

The case of a forty-five year old woman is presented who consulted for spontaneous haematomas of the thighs. The diagnosis of acquired haemophilia A associated to renal cancer was retained. She received anti CD₂₀ monoclonal antibody treatment allowing her to undergo partial nephrectomy 4 months later without major complication. One year after surgery there is no sign of tumour recurrence.

Keywords

Acquired Haemophilia, Arituximab, Renal Cancer

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	V. Toschi and F. Baudo, “Diagnosis, Laboratory Aspects and Management of Acquired Hemophilia A,” Internal and Emergency Medicine, Vol. 5, No. 4, 2010, pp. 325- 333. doi:10.1007/s11739-010-0380-y
[2]	A. Huth-Kühne, F. Baudo, P. Collins, J. Ingerslev, C. M. Kessler, H. Lévesque, M. Castellano, M. Shima M and J. St-Louis, “International Recommendations on the Diagnosis and Treatment of Patients with Acquired Hemophilia A,” Haematologica, Vol. 94, No. 4, 2009, pp. 566-575.
[3]	M. Franchini, D. Veneri, G. Lippi and R. Stenner, “The Efficacy of Rituximab in the Treatment of Inhibitor Associated Hemostatic Disorders,” Journal of Thrombosis and Haemostasis, Vol. 96, No. 2, 2006, pp. 119-125.
[4]	M. Franchini, G. Gandini, T. Di Paolantonio and G. Mariani, “Acquired Haemophilia A: A Concise Review,” American Journal of Hematology, Vol. 80, No. 1, 2005, pp. 55-63. doi:10.3324/haematol.2009.017749
[5]	M. Wermke, M. von Bonin, S. Gehrisch, G. Siegert, G. Ehninger and U. Platzbecker, “Successful Eradication of Acquired Factor-VIII-Inhibitor Using Single Low-Dose Rituximab,” Haematologica, Vol. 95, No. 3, 2010, pp. 521-522. doi:10.3324/haematol.2009.017749